Royston, UK (7th December 2011) – In collaboration with The Gurdon Institute
(University of Cambridge), Dolomite, a world leader in the design and manufacture of
microfluidic solutions, has introduced the Embryo Immobilisation Chip ideal for the
immobilization and observation of embryos or cell aggregates of up to 150µm in
Live imaging of a large number of small non-adherent samples, for a long time and at
high-resolution, has been very difficult to achieve due to movements of the sample
during handling processes. Working closely with Bernhard Stauss and The Gurdon
Institute, Dolomite has addressed these challenges by developing a novel glass
microfluidic device, optimized for high-resolution imaging and high throughput
Featuring over 250 well chambers, the Embryo Immobilisation Chip keeps samples in
position throughout imaging as well as during mounting from the microscope, allowing
observations to be carried out over a number of days. Once viewing is complete, users can easily retrieve samples from the device for further analysis, including fixation, staining or genotyping.
The microfluidic chip can be supplied with a Chip Interface which is compatible with a
wide range of standard microscope stage inserts. Offering excellent chemical
compatibility and access for optics, the Embryo Immobilisation Chip and Interface
enable users to quickly locate and observe the area of interest.
For further information on Dolomite’s range of microfluidic chips as well as a complete
portfolio of microfluidic products including chips, connectors/ interconnects, valves and
custom devices please visit www.dolomite-microfluidics.com.
The Dolomite Centre Limited
Established in 2005 as the world’s first Microfluidic Application Centre, Dolomite focused on working with
customers to turn their concepts for microfluidic applications into reality. Today, Dolomite is the world leader
in solving microfluidic problems. With offices in the UK and US and distributors throughout the rest of the
world, its clients range from universities developing leading-edge analytical equipment, to manufacturers of
chemical, life sciences and clinical diagnostics systems.
Dolomite is pioneering the use of microfluidic devices for small-scale fluid control and analysis, enabling
manufacturers to develop more compact, cost-effective and powerful instruments. By combining specialist
glass, quartz and ceramic technologies with knowledge of high performance microfluidics, Dolomite is able to
provide solutions for a broad range of application areas including environmental monitoring, clinical
diagnostics, food and beverage, nuclear, agriculture, petrochemical, cosmetics, pharmaceuticals and
chemicals. Furthermore Dolomite's in-house micro-fabrication facilities that include clean rooms and precision
glass processing facilities allow to prototype and test all solutions rapidly which ensures a faster development
cycle and reduces the time to market.
For more information please visit www.dolomite-microfluidics.com.
For more information on The Wellcome Trust/Cancer Research UK Gurdon Institute (University of Cambridge),
please visit www.gurdon.cam.ac.uk